Results 81 to 90 of about 5,013 (195)

Exploring the relationship between anorexia and therapeutic efficacy in advanced lung cancer treatment: a retrospective study

Thoracic Cancer, Volume 15, Issue 25, Page 1831-1841, September 2024.
This retrospective study explored the relationship between chemotherapy‐induced anorexia and therapeutic outcomes in patients with stage IV non‐small‐cell lung cancer undergoing platinum‐based chemotherapy combined with immune checkpoint inhibitors. Chemotherapy‐induced anorexia was observed in 13.2% of patients, who exhibited significant weight loss ...
Kosei Doshita, Tateaki Naito, Suguru Matsuda, Meiko Morita, Motoki Sekikawa, Keita Miura, Hiroaki Kodama, Michitoshi Yabe, Noboru Morikawa, Yuko Iida, Nobuaki Mamesaya, Haruki Kobayashi, Ryo Ko, Kazushige Wakuda, Akira Ono, Haruyasu Murakami, Hirotsugu Kenmotsu, Toshiaki Takahashi   +17 more
wiley   +1 more source

99mTc‐labeled, tofacitinib citrate encapsulated chitosan microspheres loaded in situ gel formulations for intra‐articular treatment of rheumatoid arthritis

Drug Development Research, Volume 85, Issue 5, August 2024.
Abstract Inflammatory diseases including rheumatoid arthritis are major health problems. Although different techniques and drugs are clinically available for the diagnosis and therapy of the disease, novel approaches regarding radiolabeled drug delivery systems are researched.
Merve Karpuz, Husniye Hande Aydin, Emre Ozgenc, Gulsah Erel‐Akbaba, Evren Atlihan‐Gundogdu, Zeynep Senyigit   +5 more
wiley   +1 more source

Serotonin signalling in cancer: Emerging mechanisms and therapeutic opportunities

Clinical and Translational Medicine, Volume 14, Issue 7, July 2024.
Primary synthesis and metabolic routes of peripheral 5‐hydroxytryptamine in the gastrointestinal tract. Advanced research has established a strong association between the serotonergic components and carcinogenic mechanisms. The interplay between serotonergic signalling and the immune system within the tumour microenvironment orchestrates antitumour ...
Lulu Chen, Shuting Huang, Xiaoxue Wu, Weiling He, Mei Song   +4 more
wiley   +1 more source

The impact of 5-hydroxytryptamine-receptor antagonists on chemotherapy treatment adherence, treatment delay, and nausea and vomiting

Cancer Management and Research, 2015
Swetha Rao Palli,1 Michael Grabner,1 Ralph A Quimbo,1 Hope S Rugo2 1HealthCore, Wilmington, DE, 2University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA Purpose: To determine the incidence of ...
Palli SR, Grabner M, Quimbo RA, Rugo HS
doaj  

Seeking American Society of Clinical Oncology‐Quality Oncology Practice Initiative (ASCO‐QOPI) certification in a northern New England rural health system and cancer care network

Learning Health Systems, Volume 8, Issue 3, July 2024.
Abstract In 2006 following several years of preliminary study, the American Society of Clinical Oncology (ASCO) launched the Quality Oncology Practice Initiative (QOPI). This cancer‐focused quality initiative evolved considerably over the next decade‐and‐a‐half and is expanding globally.
Hilary M. Perrey, Evelyn Taylor, Brett F. Cropp, Meaghan J. Bumpus, Shannon Lessard, Jeanette A. Pretorius, Jonathan H. Angus, Megan F. Duperreault, Amanda Snow, Dorothy Wang, Meredith Curtis, Lauren A. Couture, David R. Adolphson, Kimberly Smith, Joy H. Moody, Michael J. Bianchi, Mark G. Parker, Amit Sanyal, Scot C. Remick   +18 more
wiley   +1 more source

A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy

Journal of Anaesthesiology Clinical Pharmacology, 2010
Background: Postoperative nausea and vomiting (PONV) is commonly seen after laparoscopic surgery. In this randomized double blind prospective clinical study, we investigated and compared the efficacy of palonosetron and granisetron to prevent ...
Dhurjoti Prosad Bhattacharjee, Satrajit Dawn, Sushil Nayak, Pramod Ranjan Roy, Amita Acharya, Ramkrishna Dey   +5 more
doaj  

Palonosetron versus ondansetron for prophylaxis of postoperative nausea and vomiting in laparoscopic cholecystectomy: a non-inferiority randomized controlled trial

Brazilian Journal of Anesthesiology
Background: We tested the hypothesis that, within the margin of 15% of risk difference, palonosetron is not inferior to ondansetron in reducing the incidence of postoperative nausea and vomiting (PONV) in laparoscopic cholecystectomy.
Francisco Jos.. Chiaradia Davolos, Norma S. Modolo, Leandro G. Braz, Paulo do Nascimento Junior   +3 more
doaj   +1 more source

Adding aprepitant to palonosetron does not decrease carboplatin-induced nausea and vomiting in patients with gynecologic cancer [PDF]

, 2021
Yuko Watanabe, Yoshitaka Saito, Takashi Mitamura, Yoh Takekuma, Mitsuru Sugawara   +4 more
openalex   +1 more source

Efficacy of palonosetron in comparison with other 5-HT3 antagonist drugs in preventing postoperative nausea and vomiting after otorhinolaryngological surgeries: A meta-analysis

Indian Journal of Clinical Anaesthesia
Palonosetron, a 5-HT3 receptor blocker, is known to be more effective and longer-lasting in preventing postoperative nausea and vomiting (PONV).
S. Balachandar, S. Parthasarathy, R. Sripriya, S. Kulandayyan   +3 more
semanticscholar   +1 more source

Comparison of antiemetic efficacy and safety of palonosetron vs ondansetron in the prevention of chemotherapy-induced nausea and vomiting in children [PDF]

, 2015
Veerendra Patil, Harsha Prasada, Krishna Prasad, Udyavar Shenoy   +3 more
openalex   +1 more source